Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as Represented By The Secretary of the Department of Health and Human”
379 pharma patents match "The United States of America as Represented By The Secretary of the Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 379 pharmaceutical patents matching "The United States of America as Represented By The Secretary of the Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9809643
Identification of antibodies specific for at least two different lyssaviruses
granted -
US 9783579
Compositions and methods for dengue virus chimeric constructs in vaccines
granted -
US 9783590
Variants of human taste receptor genes
granted -
US 9783596
Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use
granted -
US 9700578
Use of nitrite salts for the treatment of cardiovascular conditions
granted -
US 9682107
Postnatal stem cells and uses thereof
granted -
US 9675637
Use of nitrite salts for the treatment of cardiovascular conditions
granted -
US 9650422
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
granted -
US 9598492
Human monoclonal antibodies specific for CD22
granted -
US 9592304
Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors
granted -
US 9498526
Human rotavirus vaccine strains and diagnostics
granted -
US 9486518
Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine
granted -
US 9474793
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus
granted -
US 9439935
Recombinant rift valley fever (RVF) viruses and methods
granted -
US 9435000
Primate T-lymphotropic viruses
granted -
US 9421250
Pathogenic phlebovirus isolates and compositions and methods of use
granted -
US 9415099
Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions
granted -
US 9403872
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 9387224
Treatment of specific cardiovascular conditions with nitrite
granted -
US 9382302
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9347951
Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region
granted -
US 9345758
Materials and methods for respiratory disease control in canines
granted -
US 9334522
Agents and methods to elicit anti-tumor immune response
granted -
US 9303080
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted